Evidence of neurotoxicity of ecstasy: Sustained effects on electroencephalographic activity in polydrug users

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Adamaszek, Michael ^a,b   Khaw, Alexander V ^c   Buck, Ulrike ^d   Andresen, Burghard ^b   Thomasius, Rainer ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d Institut fur Rontgendiagnostik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; ANALGESIC AGENT; CANNABIS; COCAINE; DIAMORPHINE; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT; STREET DRUG;

ADULT; ALPHA RHYTHM; ARTICLE; ATTENTION DISTURBANCE; BETA RHYTHM; CONTROLLED STUDY; DRUG MISUSE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; METHODOLOGY; MULTIPLE DRUG ABUSE; NEUROTOXICITY; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; THETA RHYTHM; ADDICTION; ADOLESCENT; ATTENTION DEFICIT DISORDER; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TOXICITY AND INTOXICATION;

ADOLESCENT; ADULT; ALPHA RHYTHM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ELECTROENCEPHALOGRAPHY; FEMALE; HALLUCINOGENS; HUMANS; MALE; MEMORY DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXICITY SYNDROMES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; THETA RHYTHM; YOUNG ADULT;

EID: 78649497837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014097     Document Type: Article

References (36)

1. ACMD Advisory Council on the Misuse of Drugs, MDMA ('ecstasy'): a review of its harms and classification under the Misuse of Drugs Act 1971, 2009. http://drugs.homeoffice.gov.uk/publication-search/acmd/mdma-report.
2. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomography evidence of toxic effect of MDMA (''Ecstasy'') on brain serotonin neurons in human beings. Lancet 352: 1-11.
3. Morgan MJ (1999) Memory deficits associated with recreational use of''ecstasy'' (MDMA). Psychopharm 141(1): 30-36.
4. Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ (2006) Neuroimaging findings with MDMD/Ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol 20: 164-175.
5. Thomasius R, Schmolke M, Kraus D (1997) MDMA (''Ecstasy'')-abuse - review of psychiatric and internal sequelae. Fortschr Neurol Psychiat 65: 49-61.
6. Capela JP, Fernandes E, Remia ̃o F, Bastos ML, Meisel A, et al. (2007) Ecstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons. Neurotoxic 28(4): 868-875.
7. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte GA (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (6) 3,4-methylenedioxymethamphetamine (MDMA,''Ecstasy''). J Neurosci 15(8): 5476-5485.
8. Hatzidimitriou G, McCann DU, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-) 3,4- methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19(12): 5096-5107.
9. Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988a) Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Research 446: 165-168.
10. Meyer JS, Brevard ME, Piper BJ, Ali SF, Ferris CF (2006) Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys. Ann N Y Acad Sci 1074: 365-376.
11. Dafters RI, Duffy F, O'Donnell PJ, Bouquet C (1999) Level of use of 3,4- Methylenedioxymeth-amphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence. Psychopharm 145(1): 82-90.
12. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH (2001) Electrophysiological evidence of serotonergic impairment in long-term MDMA (''Ecstasy'') users. Am J Psychiat 158(10): 1687-1692.
13. De Sola S, Taranćon T, Pena-Casanova J, Espadaler JM, Langohr K, et al. (2008) Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacol 200: 425-437.
14. Gamma A, Frei E, Lehmann D, Pascual RD, Hell D, Vollenweider FX (2000) Mood state and brain electric activity in Ecstasy users. Clin Neurosci Neuropsych 11: 157-162.
15. Tuchtenhagen F, Daumann J, Norra C, Gobbele ́ R, Becker S, et al. (2000) High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent Ecstasy (MDMA) users. Neuropsychopharm 22(6): 608-617.
16. Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB (1989) 3,4- methylenedioxy-methamphetamine (''Ecstasy'') selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 249(3): 713-720.
17. Oken BS, Salinsky M (1992) Alertness and Attention: Basic Science and Electrophysiologic Correlates. J Clin Neurophysiol 9(4): 480-94.
18. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, et al. (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiat 68: 719-725.
19. Thomasius R, ed (2000) Ecstasy - A study of health and psychosocial sequela to abuse. Wiss Verl Ges Stuttgart.
20. Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, et al. (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 20(2): 211-225.
21. Strüder HK, Weicker H (2001) Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Int J Sports Med 22(7): 482-497.
22. Lucas RA (1992) The human pharmacology of fluoxetine. Int JObesity 16(supp. 4): 49-54.
23. Nyström C, Matousek M, Hällström T (1988) Relationships between EEG and biochemical parameters in major depressive disorder. Acta Psychiat Scand 77: 457-465.
24. Robbins TW, Everitt BJ (1995) Arousal systems and attention. In: The cognitive neurosciences. Gazzaniga M, Bizzi E, eds. Massachusetts Institute of Technology: Cambridge, 2nd edition: pp 703-720.
25. Robertson IH, Garavan H (2004) Vigilant attention. In: The cognitive neurosciences. Gazzaniga M, ed. Massachusetts Institute of Technology: Cambridge, 3nd edition, pp 631-640.
26. Dolan RJ, Grasby P, Fletcher P, Friston KJ (1997) Measuring neuromodulation with functional imaging. In: Human brain function. Frackowiak SJ, ed. Academic press, 1. edition. pp 405-428.
27. Herrmann WM, Kubicki SK, Röhmel J (1988) Vigilance classification system: Development, sample values, and applications in nootropic drug research. Z Geront Psychiat 1: 1-33.
28. Olbrich S, Mulert C, Karch S, Trenner M, Leicht G, et al. (2009) EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage 45(2): 319-332.
29. McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). J Neurochem 54(1): 14-22.
30. Zakzanis KK, Young DA (2001) Memory impairment in abstinent MDMA (''ecstasy'') users: A longitudinal investigation. Neurol 56: 966-969.
31. Bente D (1982) Vigilance regulation, organic psychosyndrome and illnesses of the elderly: a psychophysiologic model. In: Bente D, Cooper H, Kanowski S, eds. Organic psychosyndromes of the brain in the elderly. Berlin: Springer.
32. Gouzoulis-Mayfrank E, Daumann J (2006b) The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Psychopharmacol 20(2): 188-193.
33. Verkes RJ, Gijsman HJ, Pieters M, Schoemaker RC, Visser S, et al. (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharm 153: 196-202.
34. Luu P, Tucker DM (2003) Self-regulation and the executive functions: electrophysiological clues. In: The cognitive electrophysiology of mind and brain. Zani A, Proverbio AM, eds. Academic Press: San Diego, California, pp 199-218.
35. Sato N, Ozaki TJ, Someya Y, Anami K, Ogawa S, et al. (2010) Subsequent memory-dependent EEG theta correlates to parahippocampal blood oxygenation level-dependent response. Neuroreport (online Jan 2010).
36. Cowan RL (2007) Imaging research in human MDMA users: a review. Psychopharmacol 189(4): 539-556.